| gptkbp:instanceOf | gptkb:company 
 | 
                        
                            
                                | gptkbp:acquiredBy | gptkb:Celesio gptkb:US_Oncology
 gptkb:Rexall
 
 | 
                        
                            
                                | gptkbp:CEO | gptkb:Brian_S._Tyler 
 | 
                        
                            
                                | gptkbp:competitor | gptkb:AmerisourceBergen gptkb:Cencora
 gptkb:Cardinal_Health
 
 | 
                        
                            
                                | gptkbp:country | gptkb:United_States 
 | 
                        
                            
                                | gptkbp:founded | 1833 
 | 
                        
                            
                                | gptkbp:founder | gptkb:John_McKesson gptkb:Charles_Olcott
 
 | 
                        
                            
                                | gptkbp:headquartersLocation | gptkb:Irving,_Texas,_United_States 
 | 
                        
                            
                                | gptkbp:industry | healthcare pharmaceutical distribution
 
 | 
                        
                            
                                | gptkbp:listedOn | gptkb:New_York_Stock_Exchange 
 | 
                        
                            
                                | gptkbp:notableEvent | gptkb:McKesson_&_Robbins_scandal_(1938) 
 | 
                        
                            
                                | gptkbp:numberOfEmployees | approximately 48,500 (2023) 
 | 
                        
                            
                                | gptkbp:parentCompany | gptkb:McKesson_Canada gptkb:McKesson_Medical-Surgical
 
 | 
                        
                            
                                | gptkbp:previousName | gptkb:McKesson_&_Robbins 
 | 
                        
                            
                                | gptkbp:rank | Fortune 500 #9 (2023) 
 | 
                        
                            
                                | gptkbp:revenue | $264 billion (2023) 
 | 
                        
                            
                                | gptkbp:servesArea | gptkb:Canada gptkb:Europe
 gptkb:North_America
 gptkb:United_States
 
 | 
                        
                            
                                | gptkbp:services | gptkb:insurance pharmaceutical distribution
 pharmacy management
 medical supplies distribution
 
 | 
                        
                            
                                | gptkbp:stockExchange | gptkb:NYSE 
 | 
                        
                            
                                | gptkbp:stockSymbol | gptkb:MCK 
 | 
                        
                            
                                | gptkbp:subsidiary | gptkb:CoverMyMeds gptkb:McKesson_Europe
 gptkb:RelayHealth
 
 | 
                        
                            
                                | gptkbp:type | gptkb:public_company 
 | 
                        
                            
                                | gptkbp:website | https://www.mckesson.com/ 
 | 
                        
                            
                                | gptkbp:bfsParent | gptkb:Dallas–Fort_Worth_metroplex gptkb:Dallas–Fort_Worth
 
 | 
                        
                            
                                | gptkbp:bfsLayer | 5 
 | 
                        
                            
                                | https://www.w3.org/2000/01/rdf-schema#label | McKesson 
 |